Table of contents
- Disputes and regulatory enforcement
- General Court dismisses action to annul EMA decision to disclose clinical study report (Amicus Therapeutics UK Ltd v European Medicines Agency)
- Research and development
- Horizon 2020 grant recipients asked to input information to new system
- Eighth joint BIA/MHRA conference report published
- New European Medicines Agency website launched
- Data protection and life sciences
- ‘Learning healthcare system’ needed to realise full potential of real world data
- International
- Three new guidance documents published by FDA
More sections of this document available when you sign-in to Lexis+ or register for a free trial.
Article summary
This week’s edition of Life Sciences highlights includes analysis of the General Court’s judgment dismissing an action to annul the EMA’s decision to disclose clinical study report in Amicus Therapeutics v EMA, details of a new bespoke portal for Horizon 2020 grant recipients, and news that the FDA has published three new guidance documents.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial